Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Endeavouring the latest advancements in Neuroscience and Neurological Disorders
*Corresponding Author:
Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 2020 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Neurological disorders have exaggerated lots of people universally ranging from epilepsy to Alzheimer disease, from stroke to headache. As appraised by WHO around 6.8 million people die each year due to these neurological disorders. The economic cost of neurological diseases was estimated at about 139 billion euros in 2004 in Europe.
The massive increase within the global marketplace for the neurological devices shows us the growing example of cerebral stroke, acute and chronic disorders like Epilepsy, Alzheimer’s, Parkinson’s, Huntington’s, Movement Disorders, Ataxia, Cerebrovascular disease, Multiple Sclerosis, etc…
It is estimated that 50 million U.S. people are affected by such neurological disorders which eventually lead to high expenditure treatment methods. The Transparency Market Research finds that it would reach a value of USD 13.6 billion in 2021 by the inspiring step which was available with a current report for neuroscience marketing device.
